Status:
COMPLETED
Effects of Vigiis 101-LAB on a Healthy Populations' Gut Microflora
Lead Sponsor:
SunWay Biotech Co., LTD.
Conditions:
Gastrointestinal Microbiome
Eligibility:
All Genders
20-65 years
Phase:
NA
Brief Summary
This clinical trial was conducted as part of the "Methods for Evaluating the Improvement of Gastrointestinal Function in Health Food" announced by the Department of Health, DOH (currently known as Min...
Detailed Description
1.1 Introduction The human microbiome comprises diverse microbiologic ecosystems and is composed of a variety of bacteria, archaea, microeukaryotes, and viruses. Although investigators have appreciate...
Eligibility Criteria
Inclusion
- Healthy adults aged ≧ 20 years and ≦ 65 years.
- Subjects with normal weight (body mass index: 18.5-24).
- Subjects with no gastrointestinal diseases or on medication.
Exclusion
- Pregnant or lactating women.
- Subjects who are allergic to Lactobacillus.
- Subjects with chronic gastrointestinal diseases.
- Subjects who previously underwent gastrectomy or gastric bypass.
- Subjects with liver, kidney, or heart disease, alcoholism, or uncontrolled diabetes.
- Subjects who developed stroke, psychiatric diseases, or depression within the last 1 year.
- Subjects being administered drugs that can regulate gastrointestinal function, functional foods, bacteriostatic drugs or supplements, antibiotics, antioxidants, or other unknown drugs within the last 2 weeks.
Key Trial Info
Start Date :
March 5 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 18 2016
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT04088474
Start Date
March 5 2016
End Date
December 18 2016
Last Update
September 13 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine
Taipei, Taiwan, 104